Recombinant expression vector applicable to rapid screening for recombinant strain and application
US-12037632-B2 · Jul 16, 2024 · US
US9951344B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9951344-B2 |
| Application number | US-201514879946-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2015 |
| Priority date | Oct 10, 2014 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are exogenous terminator sequences for use in fungi cell transcriptional termination.
Opening claim text (preview).
What is claimed is: 1. A fungal cell comprising an exogenous fungal transcription terminating nucleic acid sequence, wherein said fungal transcription terminating nucleic acid sequence comprises: (i) an efficiency nucleic acid sequence of the formula (TA) n1 , wherein n1 is an integer from 4 to 20; (ii) a positioning nucleic acid sequence of the formula AAWAAA, wherein W is A or T; and (iii) a polyadenylation site nucleic acid sequence comprising the sequence (N) n4 Y-A n2 , wherein N is A, C, T, or G; n4 is an integer from 0 to 10; Y is a polyadenylation site nucleotide and is C or T; and n2 is an integer from 3 to 50. 2. The exogenous fungal transcription terminating nucleic acid sequence of claim 1 , wherein n1 is 4-15. 3. The exogenous fungal transcription terminating nucleic acid sequence of claim 1 , wherein n1 is 10-14. 4. The exogenous fungal transcription terminating nucleic acid sequence of claim 1 comprising the sequence: (Sequence I) X 1 -(TA) n1 -L 1 -AAWAAA-L 2 -((N) n4 Y-A n2 ), wherein n1 is an integer from 10-20; X 1 is absent or an upstream nucleic acid sequence 2 to 20 nucleotides in length; AAW AAA is said positioning nucleic acid sequence; (N) n4 Y-A n2 is said polyadenylation site nucleic acid sequence; L 1 is a first linking nucleic acid sequence linking said positioning nucleic acid sequence to said efficiency nucleic acid sequence and L 2 is a second linking nucleic acid sequence linking said positioning nucleic acid sequence to said polyadenylation site nucleic acid sequence, wherein said first linking nucleic acid sequence and said second linking nucleic acid sequence are independently 5 to 30 nucleotides in length. 5. The exogenous fungal transcription terminating nucleic acid sequence of claim 4 , wherein X 1 is an upstream nucleic acid sequence 6 to 12 nucleotides in length. 6. The exogenous fungal transcription terminating nucleic acid sequence of claim 4 , wherein n1 is 12. 7. The exogenous fungal transcription terminating nucleic acid sequence of claim 4 , wherein W is T. 8. The exogenous fungal transcription terminating nucleic acid sequence of claim 4 , wherein n4 is an integer from 1 to 4 nucleotides and n2 is an integer from 3 to 10. 9. A fungal cell comprising an exogenous fungal transcription terminating nucleic acid sequence, wherein said fungal transcription terminating nucleic acid sequence comprises: (i) an efficiency nucleic acid sequence of the formula (TA) n1 , wherein n1 is an integer from 3 to 20; (ii) a positioning nucleic acid sequence of the formula AAWAAA, wherein W is A or T; (iii) a polyadenylation site nucleic acid sequence comprising the sequence (N) n4 Y-A n2 , wherein N is A, C, T, or G; n4 is an integer from 0 to 1 O; Y is a polyadenylation site nucleotide and is C or T; and n2 is an integer from 3 to 50; and (iv) a first linking nucleic acid sequence linking said positioning nucleic acid sequence to said efficiency nucleic acid sequence or a second linking nucleic acid sequence linking said positioning nucleic acid sequence to said polyadenylation site nucleic acid sequence, wherein said first linking nucleic acid sequence and said second linking nucleic acid sequence are independently 3 to 30 nucleotides in length and consist of less than about 35% of cytosine and guanine. 10. The exogenous fungal transcription terminating nucleic acid sequence of claim 9 , wherein said first linking nucleic acid sequence or said second linking nucleic acid sequence consists of less than about 30% cytosine and guanine. 11. The exogenous fungal transcription terminating nucleic acid sequence of claim 9 , wherein said first linking nucleic acid sequence is about 10-25 nucleotides in length. 12. A fungal cell comprising an exogenous fungal transcription terminating nucleic acid sequence, wherein said fungal transcription terminating nucleic acid sequence comprises: (i) an efficiency nucleic acid sequence of the formula (TA) n1 , wherein n1 is an integer from 3 to 20; (ii) a positioning nucleic acid sequence of the formula AAWAAA, wherein W is A or T; (iii) a polyadenylation site nucleic acid sequence comprising the sequence (N) n4 Y-A n2 , wherein N is A, C, T, or G; n4 is an integer from 0 to 10; Y is a polyadenylation site nucleotide and is C or T; and n2 is an integer from 3 to 50; (iv) an upstream nucleic acid sequence 5′ to said efficiency nucleic acid sequence of the formula (T) n3 , wherein n3 is an integer from 2 to 20. 13. The exogenous fungal transcription terminating nucleic acid sequence of claim 12 , wherein n1 is an integer of 3 to 12. 14. The exogenous fungal transcription terminating nucleic acid sequence of claim 12 , wherein n3 is an integer from 4 to 12. 15. The exogenous fungal transcription terminating nucleic acid sequence of claim 12 , further comprising a first linking nucleic acid sequence linking said positioning nucleic acid sequence to said efficiency nucleic acid sequence. 16. The exogenous fungal transcription terminating nucleic acid sequence of claim 1 , wherein said exogenous fungal transcription terminating nucleic acid sequence includes a length of less than about 200 nucleotides. 17. An expression construct comprising an exogenous fungi transcription terminating nucleic acid sequence of claim 1 . 18. A method of expressing a gene in a fungal cell, said method comprising: (i) transforming the fungal cell of claim 1 with an expression construct comprising a gene operably linked to the exogenous fungal transcription terminating nucleic acid sequence; (ii) allowing said cell to express said expression construct, wherein said exogenous fungal transcription terminating nucleic acid sequence modulates a level of transcription of said gene, thereby expressing said gene in said fungal cell.
for fungi · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.